Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Reverse Mutation E143K within the PrM Protein of Zika Virus Asian Lineage Natal RGN Strain Increases Infectivity and Cytopathicity. | Viruses | 2022 | 35891552 | PubTator, text mining | PubMed |
| Identification of Target Proteins Involved in Cochlear Hair Cell Progenitor Cytotoxicity following Gentamicin Exposure. | J Clin Med | 2022 | 35887836 | PubTator, text mining | PubMed |
| Non-Canonical Programmed Cell Death in Colon Cancer. | Cancers (Basel) | 2022 | 35884370 | PubTator, text mining | PubMed |
| The Role of Pyroptosis and Autophagy in Ischemia Reperfusion Injury. | Biomolecules | 2022 | 35883566 | PubTator, text mining | PubMed |
| Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation. | Biomolecules | 2022 | 35883480 | PubTator, text mining | PubMed |
| Immune Response of the Monocytic Cell Line THP-1 Against Six Aeromonas spp. | Front Immunol | 2022 | 35874671 | PubTator, text mining | PubMed |
| Bibliometric Analysis of Cathepsin B Research From 2011 to 2021. | Front Med (Lausanne) | 2022 | 35872750 | PubTator, text mining | PubMed |
| Current knowledge of pyroptosis in heart diseases. | J Mol Cell Cardiol | 2022 | 35868567 | PubTator, text mining | PubMed |
Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 35866781 | PubTator, text mining | PubMed |
| Lipid A Variants Activate Human TLR4 and the Noncanonical Inflammasome Differently and Require the Core Oligosaccharide for Inflammasome Activation. | Infect Immun | 2022 | 35862709 | PubTator, text mining | PubMed |
| Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. | Front Oncol | 2022 | 35860590 | PubTator, text mining | PubMed |
| Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies. | Cancer Biol Med | 2022 | 35856558 | PubTator, text mining | PubMed |
| Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma. | Int J Gen Med | 2022 | 35855761 | PubTator, text mining | PubMed |
| Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma. | Front Oncol | 2022 | 35847844 | PubTator, text mining | PubMed |
| Think Beyond Particle Cytotoxicity: When Self-Cellular Components Released After Immunogenic Cell Death Explain Chronic Disease Development. | Front Toxicol | 2022 | 35846433 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer. | Front Genet | 2022 | 35846123 | PubTator, text mining | PubMed |
| A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy. | Dis Markers | 2022 | 35845137 | PubTator, text mining | PubMed |
| Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β. | Front Immunol | 2022 | 35844548 | PubTator, text mining | PubMed |
| Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19. | Cell Death Discov | 2022 | 35842415 | PubTator, text mining | PubMed |
| Disulfiram ameliorates ischemia/reperfusion-induced acute kidney injury by suppressing the caspase-11-GSDMD pathway. | Ren Fail | 2022 | 35837696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=40